Abstract
Within the brain, quinolinic acid (QUIN) is an important neurotoxin, especially in AIDS dementia complex (ADC). Its production by monocytic lineage cells is increased in the context of inflammation. However, it is not known whether QUIN promotes inflammation. Astrocytes are important in immuno-regulation within the brain and so we chose to examine the effects of QUIN on the astrocyte. Using purified cultures of primary human foetal astrocyte, we determined chemokine production using ELISA assays and RT-PCR, and chemokine receptor expression using immunocytochemistry and RT-PCR with QUIN in comparison to TNF-a/IFN-y. We found that QUIN induces astrocytes to produce large quantities of MCP-1 (CCL2), and lesser amounts of RANTES (CCL5), IL-8 (CXCL8). QUIN also increases SDF-la (CXCL12), HuMIG (CXCL9) and fractalkine (CX3CL1) mRNA expression. Moreover, QUIN leads to up-regulation of the chemokine receptor expression of CXCR4, CCR5, and CCR3 in human foetal astrocytes. Most of these effects were comparable to those induced by TNF-a/IFN-y. The present work represents the first evidence that QUIN induces chemokine and chemokine receptor expression in astrocytes and is at least as potent as classical mediators such as inflammatory cytokines. These results suggest that QUIN may be critical in the amplification of brain inflammation particularly in ADC.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
T.W. Stone, Endogenous neurotoxins from tryptophanToxicon39, 61–73 (2001).
P. Conti, R.C. Barbacane, M. Reale, Chemokines in inflammatory statesAllergy Asthma Proc.20, 205–208 (1999).
R.S. Ghirnikar, Y.L. Lee, L.F Eng„ Inflammation in traumatic brain injury: role of cytokines and chemokinesNeurochem. Res.23, 329–340 (1998).
B.A. Premack, T.J. Schall, Chemokine receptors: gateways to inflammation and infectionNature Medecine2, 1174–1178 (1996).
M. Baggiolini, Chemokines and leukocyte trafficNature392, 565–568 (1998).
F. Balkwill, The molecular and cellular biology of the chemokinesJ. Viral Nepal. 5, I-14 (1998).
P.M. Murphy, M. Baggiolini, I.F. Charo, C.A. Hebert, R. Horuk, K. Matsushima, L.H. Miller, J.J. Oppenheim, C.A. Power, International union of pharmacology. XXII. Nomenclature for chemokine receptorsPharmacol. Rev.52, 145–176 (2000).
J.M. Weiss, S.A. Downie, W.D. Lyman, J.W Berman,. Astrocyte-derived monocyte-chemoattractant protein-I directs the transmigration of leukocytes across a model of the human blood-brain barrierJ. Immunol.161, 6896–6903 (1998).
P. Bezzi, M. Domercq, L. Brambilla, R. Galli, D. Schols, E. De Clercq, A. Vescovi, G. Bagetta, G. Kollias, J. Meldolesi, A. Volterra, CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicityNat. Neurosci.4, 702–710. (2001).
M. Cota, A. Kleinschmidt, F. Ceccherini-Silberstein, F. Aloisi, M. Mengozzi, A. Mantovani, R. Brack-Werner, G. Poli, Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1J. Neurovirol.6, 75–83 (2000).
J. Croitoru-Lamoury, G. Guillemin, F.D. Boussin, B. Mognetti, S. Lebel-Binay, T. Leveque, G. Gras, R. Le Grand, D. Dormont, Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF-a and IFN-g in CXCR4 and CCRS modulationGliain press. (2002).
J.W. Oh, L.M. Schwiebert, E.N. Benveniste, Cytokine regulation of CC and CXC chemokine expression by human astrocytesJ. Neurovirol.5, 82–94 (1999).
P. Rezaie, G. Trillo-Pazos, I.P. Everall, D.K. Male, Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNSGlia37, 64–75 (2002).
V.C. Asensio, I.L. Campbell, Chemokines in the CNS: plurifunctional mediators in diverse statesTrends Neurosci.22, 504–512 (1999).
A.R. Glabinski, R.M. Ransohoff, Chemokines and chemokine receptors in CNS pathology.J. Neurovirol.5, 3–12 (1999).
A.E.I. Proudfoot, Chemokine receptors: multifaceted therapeutic targetsNat. Rev. Immunol.2, 106–115 (2002).
B. Moser, Chemokines and HIV: a remarkable synergismTrends in Microbiology5, 88–90 (1997).
A. Boutet, H. Salim, Y. Taoutik, P.M. Lledo, J.D. Vincent, J.F. Delfraissy, M. Tardieu, Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-I strains despite functional expression of the chemokine receptors CCR5 and CXCR4Glia34, 165–177. (2001).
D. Gabuzda, J. Wang, Chemokine receptors and virus entry in the central nervous system.J. Neurovirol.5, 643–658 (1999).
J. Hesselgesser, R. Horuk, Chemokine and chemokine receptor expression in the central nervous systemJ. Neurovirol.5, 13–26 (1999).
A.V. Andjelkovic, D. Kerkovich, J. Shanley, L. Pulliam, J.S. Pachter, Expression of binding sites for beta chemokines on human astrocytesGlia28, 225–235 (1999).
M.E. Dorf, M.A. Berman, S. Tanabe, M. Heesen, Y Luo,. Astrocytes express functional chemokine receptorsJ. Neuroimmunol.111, 109–121. (2000).
R.S. Klein, K.C. Williams, X. Alvarez-Hernandez, S. Westmoreland, T. Force, A.A. Lackner, A.D. Luster, Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDSJ. Immunol.163, 1636–1646 (1999).
F. Sabri, E. Tresoldi, M. Di Stefano, S. Polo, M.C. Monaco, A. Verani, J.R. Fiore, P. Lusso, E. Major, F. Chiodi, G. Scarlatti, Nonproductive human immunodeficiency virus type I infection of human fetal astrocytes: independence from CD4 and major chemokine receptorsVirology264, 370–384 (1999)
R.R. Brown, Y. Ozaki, S.P. Datta, E.C. Borden, P.M. Sondel, D.G. Malone, Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDSAdv. Exp. Med. Biol. 294, 425-435 (1991).
J.M. Carlin, Y. Ozaki, G.I. Byrne, R.R. Brown, E.C. Borden, Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effectsExperientia45, 535–541 (1989).
G. Melillo, G.W. Cox, A. Biragyn, L.A. Sheffler, L. Varesio, Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acidJ. Biol. Chem.269, 8128–8133 (1994).
Y. Ozaki, M.P. Edelstein, D.S. Duch, Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gammaProc. Natl. Acad. Sci. U. S. A.85, 1242–1246 (1988).
Y. Kudo, C.A. Boyd, Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejectionBiochim. Biophys. Acta1500, 119–124 (2000).
T. Nicholls, B. Lacey, I. Nitsos, G. Smythe, D.W. Walker, Regional changes in kynurenic acid, quinolinic acid, and glial tibrillary acidic protein concentrations in the fetal sheep brain after experimentally induced placental insufficiencyAm. J Obstet. Gynecol.184, 203–208 (2001).
G. Melillo, G.W. Cox, D. Radzioch, L. Varesio, Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophagesJ. Immunol.150, 4031–4040 (1993).
M.C. Bosco, A. Rapisarda, S. Massazza, G. Melillo, H. Young, L. Varesio, The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -lbeta in macrophages [In Process Citation].J. Immunol.164, 3283–3291 (2000).
B.J. Brew, L. Pemberton, L. Evans, M. Heyes, Quinolinic acid production by macrophages infected with demented and non-demented isolates of HIVClin. Neuropathol.12, SI (1993).
M.P. Heyes, B.J. Brew, A. Martin, R.W. Price, A.M. Salazar, J.J. Sidtis, J.A. Yergey, M.M. Mouradian, A.E. Salder, J. Keilp, D. Rubinow, S.P. Markey, Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological statusAnn. Neurol.29, 202–209 (1991).
B.J. Brew, L. Pemberton, P. Cunningham, M.G. Law, Levels of human immunodeficiency virus type I RNA in cerebrospinal fluid correlate with AIDS dementia stageJ. Infect. Dis.175, 963–966 (1997).
M.G. Espey, O.N. Chernyshev,I.I. Reinhard, M.A. Namboodiri, C.A. Colton, Activated human microglia produce the excitotoxin quinolinic acidNeuroreport8, 431–434 (1997).
G.J. Guillemin, S.J. Kerr:, G.A. Smythe, D.G. Smith, V. Kapoor, P.J. Armati, J. Croitoru, B.J. Brew, Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protectionJ. Neurochem.781–13 (2001).
J. Croitoru, G. Guillemin, F.D. Boussin, B. Mognetti, S. Lebel-Binay, T. Leveque, G. Gras, R. Le Grand, D. Dormont, Chemokines and chemokine receptors expression in simian astrocytesSSA Tray. Scient.20, 141–142 (1999).
A.V. Andjelkovic, D. Kerkovich, J.S. Pachter, Monocyte:astrocyte interactions regulate MCP-1 expression in both cell typesJ. Leukoc. Biol.68, 545–552 (2000).
D.A. Barnes, M. Huston, R. Holmes, E.N. Benveniste, V.W. Yong, P. Scholz, H.D. Perez, Induction of RANTES expression by astrocytes and astrocytoma cell linesJ. Neuroimmunol.71, 207–214 (1996).
H. Guo, Y.X. Jin, M. Ishikawa, Y.M. Huang, P.H. van der Meide, H. Link, B.G. Xiao, Regulation of betachemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokinesScand. J. Immunol.48, 502–508 (1998).
N. Janabi, I. Hau, M. Tardieu, Negative Feedback Between Prostaglandin and alpha-and beta-Chemokine Synthesis in Human Microglial Cells and AstrocytesJ. Immunol.162, 1701–1706 (1999).
P.K. Peterson, S. Hu, J. Salak-Johnson, T.W. Molitor, C.C. Chao, Differential production of and migratory response to beta chemokines by human microglia and astrocytesJ. Infect. Dis.175, 478–481 (1997).
D. Sun, X. Hu, X. Liu, J.N. Whitaker, W.S. Walker, Expression of chemokine genes in rat glial cells: the effect of myelin basic protein-reactive encephalitogenic T cellsJ. Neurosci. Res.48, 192–200 (1997).
A.V. Andjelkovic, D.D. Spencer, J.S. Pachter, Visualization of chemokine binding sites on human brain microvesselsJ. Cell. Bio.145, 403–412 (I 999).
R. Brack-Wemer, Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesisAids13, 1–22 (1999).
.C.C. BIeuI, M. Farzan, H. Choe, C. Parolin, J. Clark-Lewis, I. Sodroski, T.A. Springer, The lymphocyte chemoattractant SDF-1 is a ligand for LESTER/fusin and blocks HIV-1 entryNature382, 829–832 (1996).
J.M. Farber, Mig and IP-10: CXC chemokines that target lymphocytesJ. Leukoc. Biol.61, 246–257 (1997).
D. Maciejewski-Lenoir, S. Chen, L. Feng, R. Maki, K.B. Bacon, Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microgliaJ. Immunol.163, 1628–1635 (1999).
O. Meucci, A. Fatatis, A.A. Simen, R.J. Miller, Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survivalProc. Natl. Acad. Sci. U. S. A.97, 8075–8080 (2000).
S.A. Boehme, F.M. Lio, D. Maciejewski-Lenoir, K.B. Bacon, P.J. Conlon, The chemokine fractalkine inhibits Fas-mediated cell death of brain microgliaJ. Immunol.165, 397–403 (2000).
A.V. Vallat, U. De Girolami, J. He, A. Mhashilkar, W. Marasco, B. Shi, F. Gray, J. Bell, C. Keohane, T.W. Smith, D. Gabuzda, Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDSAm. J. Pathol.152, 167–178 (1998).
M.Q. Xia, S.X. Qin, L.J. Wu, C.R. Mackay, B.T. Hyman, Immunohistochemical study of the betachemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer’s disease brains.Am. J. Pathol.153, 31–37 (1998).
L. Zhang, T. He, A. Talal, G. Wang, S.S. Frankel, D.D. Ho, In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5J. Virol.72, 5035–5045 (1998).
M.P. Heyes, K.J. Swartz, S.P. Markey, M.F. Beal, Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington’s diseaseNeurosci. Lett.122, 265–269 (1991).
Y.R. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi, D.R. Littman, Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature393, 595–599 (1998).
J.B. Rottman, K.P. Ganley, K. Williams, L. Wu, C.R. Mackay, D.J. Ringler, Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infectionAm. J. Pathol. 151, 1341-1351 (1997).
S.J. Kerr, P.J. Armati, L.A. Pemberton, G. Smythe, B. Tattam, B.J. Brew, Kynurenine pathway inhibition reduces toxicity of HIV-infected macrophagesNeurology49, 1671–1681 (1997).
S.J. Kerr, P.J. Armati, G.J. Guillemin, B.J. Brew, Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complexAIDS12, 355–363 (1998).
L.A. Pemberton, S.J. Kerr, B.J. Brew, HIV-1 gp120 does not induce quinolinic acid production by macrophages (Letter)J. NeuroVirol.3, 86–87 (1997).
D.G. Smith, G.J. Guillemin, L. Pemberton, S. Kerr, A. Nath, G.A. Smythe, B.J. Brew, Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and TatJ. Neurovirol.7, 56–60 (2001).
J.T. Coyle, R. Schwartz, Mind glue: implications of glial cell biology for psychiatryArch. Gen. Psychiatry.57, 90–93 (2000).
K.B. Bacon, J.K. Harrison, Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasisJ. Neuroimmwtol.104, 92–97 (2000).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Croitoru-Lamoury, J., Guillemin, G.J., Dormont, D., Brew, B.J. (2003). Quinolinic Acid Up-Regulates Chemokine Production and Chemokine Receptor Expression in Astrocytes. In: Allegri, G., Costa, C.V.L., Ragazzi, E., Steinhart, H., Varesio, L. (eds) Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology, vol 527. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0135-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0135-0_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4939-6
Online ISBN: 978-1-4615-0135-0
eBook Packages: Springer Book Archive